Laura van't Veer
Fondateur chez Agendia, Inc.
Postes actifs de Laura van't Veer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur Technique/Scientifique/R&D | 29/01/2010 | - |
| Fondateur | 29/01/2010 | - | |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Corporate Officer/Principal | - | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Fondateur | 01/01/2003 | - |
| Corporate Officer/Principal | 01/01/2003 | - |
Historique de carrière de Laura van't Veer
Anciens postes connus de Laura van't Veer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
| Pays-Bas | 3 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
| Miscellaneous | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Miscellaneous |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
- Bourse
- Insiders
- Laura van't Veer
- Expérience
